TP53 and endometrial endometrioid carcinoma: Thus, the primary objective of this systematic review and meta-analysis was to collate and summarize the available data on the oncologic outcomes (including overall survival (OS) and progression-free survival (PFS)) of patients with abnormal p53 G3 endometrioid endometrial carcinoma.